Official partnerships across the world's leading medical systems.

The Cancer Institute Hospital of JFCR, established in 1934 in Tokyo, is Japan's foremost cancer hospital with over 100 years of institutional history. It has 700 beds and performs over 7,000 surgeries annually — the highest volume among Japanese cancer hospitals. The hospital is world-renowned in digestive system cancer surgery, particularly minimally invasive laparoscopic procedures for gastric, colorectal, and esophageal cancers. It has treated over 1,000 international cancer patients, the most among Japanese cancer centers.

St. Luke's International Hospital, founded in 1901 in Tokyo, was ranked Japan's #1 comprehensive hospital by Newsweek in 2020. In 2017, the hospital recorded 638,000 outpatient visits and 176,000 inpatient admissions, including over 30,000 international patients from 136 countries. It has a sister hospital agreement with MD Anderson Cancer Center and is a pioneer in Japanese precision health screening (ningen dock).

The University of Tokyo Hospital, founded in 1858, is Japan's most prestigious university hospital with over 160 years of history. In 2020, Newsweek ranked it among the world's top 20 hospitals. The university has produced 11 Nobel Prize laureates. In 2020, the hospital established its International Health Screening Center, providing comprehensive preventive health services with dedicated VIP facilities and personal accompaniment.

Keio University Hospital, founded in 1920 in Tokyo, is the teaching hospital of one of Japan's most prestigious private universities. It houses 31 clinical departments averaging 3,000+ daily outpatient visits and over 16,000 annual surgeries. Designated as a Core Clinical Research Hospital and Cancer Genomic Medicine Core Hospital, Keio achieved the world's first living-donor liver transplant for congenital heart disease (2009) and the world's first inner-ear cell regeneration surgery (2013).

Toranomon Hospital, established in 1958 in central Tokyo, provides acute-phase comprehensive medical services across a wide spectrum of specialties. A new 19-story hospital building opened in 2019 with 819 beds and 20 operating theaters. Its Cancer Comprehensive Treatment Base leverages multi-specialty strength for patients with multiple comorbidities, and its Cardiovascular Center aims to be Japan's leading cardiac center.

Institute of Science Tokyo Hospital (formerly Tokyo Medical and Dental University Hospital) is the teaching hospital of Japan's only comprehensive medical university. The dentistry program ranks #1 in Japan and in the world's top 10, while the medical school ranks among Japan's top 3. The hospital has 41 clinical departments receiving approximately 580,000 outpatient visits annually. It is a national leader in spine surgery and pioneered the world's first synovium-derived stem cell transplantation.

Shonan Kamakura General Hospital, relocated to a new 15-story facility in 2010, is a comprehensive acute-care hospital with 648 beds and 1,713 staff. Part of the Tokushukai Group operating under the philosophy that 'only life is equal,' it was the first hospital in Japan to receive JMIP certification for international patient services. The hospital operates 24/7, 365 days a year, never refusing emergency patients.

QST Hospital, founded in 1961 in Chiba, Japan, is the world's pioneer and leading institution for heavy ion radiotherapy. Since beginning treatment in 1994, it has treated over 15,000 patients — the highest number worldwide — with approximately 80% five-year tumor control rates. In 2018, it achieved the world's first superconducting rotating gantry for heavy ion therapy. Cancers treatable include lung, liver, pancreatic, skull base, head and neck, prostate, and bone/soft tissue tumors.

Kyoundo Hospital, founded in 1882 in Tokyo, is one of Japan's most historic private hospitals. The hospital has experience serving the Japanese Imperial Household and offers integrated care from precision health screening to surgery, chemotherapy, radiotherapy, immunotherapy, and palliative care. Its laparoscopic surgery rate of 89.9% far exceeds Japan's national average of 20%. The hospital excels in oncology — particularly breast, ovarian, testicular, and esophageal cancers.